Please select the option that best describes you:

How do you distinguish between primary progressive MS versus relapsing remitting MS with superimposed relapses in a newly diagnosed patient that is naive to treatment?  

Are there emerging biomarkers that help distinguish the phenotypes in the absence of evaluation over time?



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: at Academic Institution
Sign in or Register to read more